Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
Launched by RENNES UNIVERSITY HOSPITAL · Mar 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and preventing nausea and vomiting caused by chemotherapy or radiation treatment in children and adolescents with cancer. These symptoms, known as chemotherapy- or radiation-induced nausea and vomiting (CRVN), are common and can be very distressing for both young patients and their families. The goal of the study is to find out which children and teenagers are most at risk of experiencing these symptoms, so that doctors can take steps to prevent them before treatment begins.
To participate in this trial, children and teens must be receiving chemotherapy or radiation therapy at a specific pediatric cancer center. If they are under 18, at least one parent must agree to their participation. It's important to note that the study will not include patients who have difficulty understanding French or those under legal protection. Participants can expect to be part of a study that aims to improve their treatment experience by reducing the likelihood of nausea and vomiting, ultimately helping them feel more comfortable during their cancer care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treated in a pediatric onco-hematology center in the GOCE (Grand Ouest Cancer Enfant) inter-region;
- • Receiving chemotherapy or radiotherapy;
- * According to patient age :
- • Minor (under 18 years): At least one parent has been informed of the protocol and has not expressed opposition to the child's participation in the study
- • Adult (more than 18 years): Having received information about the protocol and not having expressed opposition to participating in the study
- Exclusion Criteria:
- • Patients or legal representatives with French understanding difficulties.
- • Patients or legal representatives subject with legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty.
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Angers, , France
Rennes, , France
Tours, , France
Caen, , France
Saint Herblain, , France
Patients applied
Trial Officials
Maïna LETORT-BERTRAND
Principal Investigator
CHU Rennes Hôpital Sud
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported